Status:
ENROLLING_BY_INVITATION
The Effect of Liposomal Bupivacaine Nerve Block (Exparel) in Rotator Cuff Surgery
Lead Sponsor:
The Cooper Health System
Conditions:
Rotator Cuff Tears
Postoperative Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The goal of this clinical trial is to investigate if there is a difference in pain after an arthroscopic rotator cuff surgery when a nerve block is performed with liposomal bupivacaine versus the stan...
Detailed Description
Nerve blocks are typically performed for shoulder surgery for perioperative pain control. This is performed in the shoulder using an interscalene block, which is localized between the anterior and mid...
Eligibility Criteria
Inclusion
- Patients above 18 years of age
- Undergoing rotator cuff surgery or shoulder arthroscopy using an interscalene block
Exclusion
- Patients with preexisting chronic obstructive pulmonary disease (COPD) or respiratory issues precluding the use of an interscalene block
- Pregnant women, women nursing infants
- Patients with preexisting liver disease
- Patients unwilling to have interscalene block performed
- Patients allergic to bupivacaine, liposomal bupivacaine, or any ingredients contained within the two drugs listed
Key Trial Info
Start Date :
July 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT06139666
Start Date
July 11 2019
End Date
June 1 2025
Last Update
August 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cooper University Hospital
Camden, New Jersey, United States, 08103